Galapagos | GLPG - Assets

Stock Price
30.16
Daily Change
1.76 6.20%
Monthly
4.22%
Yearly
19.68%
Q1 Forecast
27.85

Galapagos reported EUR3.51B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Incyte USD 6.96B 627.62M Dec/2025
Merck EUR 50.93B 3.58B Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025